ConcertAI's TeraRecon has launched an artificial intelligence (AI)-driven software package called Neuro Suite.
Neuro Suite is intended to help with disease evaluation and treatment strategies, the company said.
The company also highlighted TeraRecon Eureka Clinical AI, which offers a portfolio of software related to neurology, including Combinostics, Imaging Biometrics, and Cercare.
Combinostics' algorithm provides brain segmentation assessment on MRI images to evaluate atrophy. Imaging Biometric's algorithm helps clinicians assess the oxygenation and blood supply of brain tumors. Cercare's perfusion technology gives clinicians insights into blood flow and cerebral blood volume for assessment of neurovascular function down to the capillary level.
